Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – What’s Next?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) gapped up prior to trading on Monday . The stock had previously closed at $6.88, but opened at $7.16. Coloplast A/S shares last traded at $7.19, with a volume of 11,728 shares trading hands.

Analysts Set New Price Targets

Separately, Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Coloplast A/S has a consensus rating of “Hold”.

Coloplast A/S Stock Up 5.2%

The company has a market capitalization of $16.32 billion, a price-to-earnings ratio of 38.11, a P/E/G ratio of 2.66 and a beta of 0.13. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.09 and a current ratio of 1.75. The stock’s fifty day simple moving average is $6.30 and its two-hundred day simple moving average is $6.63.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.10. The firm had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.11 billion. Coloplast A/S had a net margin of 9.68% and a return on equity of 38.81%. On average, sell-side analysts anticipate that Coloplast A/S Sponsored ADR will post 0.39 EPS for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.